Studies on the effectiveness of Tanacetum parthenium against Leishmania amazonensis

Acta Protozoologica

Volumn 44, Issue 3, 2005, Pages 245-251

  Tiuman, Tatiana Shioji ^a   Ueda Nakamura, Tânia ^a   Dias Filho, Benedito Prado ^a   Cortez, Diógenes Aparício Garcia ^a   Nakamura, Celso Vataru ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Antileishmanial activity; Cytotoxicity; Leishmania amazonensis; Medicinal plants; Tanacetum parthenium

Indexed keywords

LEISHMANIA AMAZONENSIS; PROTOZOA; TANACETUM PARTHENIUM;

EID: 24344498226     PISSN: 00651583     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abad M. J., Bermejo P., Villar A. (1995) An approach to the genus Tanacetum L. (Compositae): phytochemical and pharmacological review. Phytother. Res. 9: 79-92
2. Alvar J., Cañavate C., Gutiérrez-Solar B., Jiménez M., Laguna F., López-Vélez R., Molina R., Moreno J. (1997) Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 10: 298-319
3. Bennett J. E. (1996) Fármacos antimicrobianos (continuaç ão): fármacos antifúngicos. In: As Bases Farmacológicas da Terapêutica, (Eds. L.S. Goodman, A. Gilman). McGraw-Hill, México, 9ed., 864-875
4. Berman J. D. (1996) Treatment of New World cutaneous and mucosal leishmaniasis. Clin. Dermatol. 14: 519-522
5. Berman J. D. (1997) Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24: 684-703
6. Calixto J. B. (2000) Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz. J. Med. Biol. Res. 33: 179-189
7. Camacho D. D. R., Phillipson J. D., Croft S. L., Solis P. N., Marshall S. J., Ghazanfar S. A. (2003) Screening of plant extracts for antiprotozoal and cytotoxic ativities. J. Ethnopharmacol. 89: 185-191
8. Croft S. L., Coombs G. H. (2003) Leishmaniasis - current chemotherapy and recent advances in the seach for novel drugs. Trends Parasitol. 19: 502-508
9. Edzard E. (1998) Harmless herbs? A review of the recent literature. Am. J. Med. 104: 170-178
10. Fournet A., Barrios A. A., Muñoz V. (1994) Leishmanicidal and trypanocidal activities of Bolivian medicinal plants. J. Ethnopharmacol. 41: 19-37
11. Grevelink S. A., Lerner E.A. (1996) Leishmaniasis. J. Am. Acad. Dermatol. 34: 257-272
12. Hamburger M., Hostettmann K. (1991) Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry 30: 3864-3874
13. Heptinstall S., Williamson L., White A., Mitchell J. R.A. (1985) Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet North Am. Ed. 325: 1071-1074
14. Jain N. K., Kulkarni S. K. (1999) Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats. J. Ethnopharmacol. 68: 251-259
15. Martindale (1999) Feverfew. In: Martindale: the Complete Drug Reference, (Ed. K. Parfitt). The Pharmaceutical Press, London, 32ed., 447
16. Mendonça-Filho R. R., Rodrigues I. A., Alviano D. S., Santos A. L. S., Soares R. M. A., Alviano C. S., Lopes A. H. C. S., Rosa M. S. S. (2004) Leishmanicidal activity of polyphnolic-rich extract from husk fiber of Cocos nucifera Linn. (Palmae). Res. Microbiol. 155: 136-146
17. Murphy J. J., Heptinstall S., Mittchel J. R. A. (1988) Randomised double-bind placego-controlled trial of feverfew in migraine prevention. Lancet North Am. Ed. 332: 189-192
18. Newall C. A., Anderson L. A., Phillipson J. D. (2002) Matricária. In: Plantas Medicinais: Guia Para Profissional de Saúde, (Eds. C. A. Newall, L. A. Anderson, J. D. Phillipson). Editorial Premier, São Paulo, 191-193
19. Pan A. A., Duboise M., Eperon S., Rivas L., Hodgkinson V., Traub-Cseko Y., McMahon-Prati D. (1993) Developmental life cycle of Leishmania - cultivation and characterization of cultured extracellular amastigotes. J. Euk. Microbiol. 40: 213-223
20. Piela-Smith T. H., Liu X. (2001) Feverfew and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts. Cell. Immunol. 209: 89-96
21. Rates S. M. K. (2001) Plants as source of drugs. Toxicon 39: 603-613
22. Rosa M. S. S., Mendonça-Filho R. R., Bizzo H. R., Rodrigues I. A., Soares R. M. A., Souto-Padrón T., Alviano C. S., Lopes A. H. C. S. (2003) Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob. Agents Chemother. 47: 1895-1901
23. Salvador M. J., Ferreira E. O., Pral E. M. F., Alfieri S. C., Albuquerque S., Ito I. Y., Dias D. A. (2002) Bioactivity of crude extracts and some constituents of Blutaparon protulacoides (Amarantheceae). Phytomedicine 9: 566-571
24. Shu Y. (1998) Recent natural products based drug development: a pharmaceutical industry perspective. J. Nat. Prod. 61: 1053-1071
25. Sumner H., Salan U., Knight D. W., Hoult J. R. S. (1992) Inhibition of 5-lipoxigenase and cyclo-oxigenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components. Biochem. Pharmacol. 43: 2313-2320
26. Ueda-Nakamura T., Attias M., De Souza W. (2001) Megasome biogenesis in Leishmania amazonensis: a morphometric and cytochemical study. Parasitol. Res. 87: 89-97
27. Weniger B., Robledo S., Arango G. J., Deharo E., Aragón R., Muñoz V., Callapa J., Lobstein A., Anton R. (2001) Antiprotozoal activities of Colombian plants. J. Ethnopharmacol. 78: 193-200
28. Williams C. A., Harborne J. B., Geiger H., Hoult J. R. S. (1999) The flavonoids of Tanacetum parthenium and T. vulgare and their anti-inflamatory properties. Phytochemistry 51: 417-423
29. World Health Organization (2001) Leishmaniasis: the disease and its impact. [Online] http://www.who.int/emc/diseases/leish/leisdis1.html, acessed in 14 April 2003
30. Wright C. W., Phillipson J. D. (1990) Natural products and the development of selective antiprotozoal drugs. Phytother. Res. 4: 127-139